Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Icahn Enterprises target raised to $40 at UBS; Despite jump in NAV, results continue to suffer from poor investment returns (54.38 +0.58)UBS raises their IEP tgt to $40 from $30 following Q4 earnings. The driver of the miss was a larger than expected negative return at the hedge fund (-8.7% vs --3% est) and higher operating expenses, partially offset by minority interest and a tax benefit. The weaker hedge fund results were driven by a negative performance attribution of 10% on IEP's short positions that were only partially offset by gains on longs of 1.3%. The fund remains net short 128% (down from 138% last quarter) and <strong>given the continued advance in the broad market indices QTD firm remains skeptical of a NT turnaround in performance. Notably, IEP announced it has hired Dr. Richard Mulligan for biotech investments, a sector where IEP has been active in the past.</strong></td> </tr></table>"